🇺🇸 FDA
Pipeline program

Clostridium butyricum (live) Tablets(Meiya)

KY2025-1273

Unknown mab active

Quick answer

Clostridium butyricum (live) Tablets(Meiya) for Rectal Cancer is a Unknown program (mab) at ROCKET PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ROCKET PHARMACEUTICALS, INC.
Indication
Rectal Cancer
Phase
Unknown
Modality
mab
Status
active

Clinical trials